3239 results for «2015»

Filter By

3239 results

Advanced techniques for managing calcified lesions

22 Sep 2023 – From AICT-AsiaPCR 2023

Discover advanced strategies for tackling complex calcified lesions in this session: from innovative approaches like the 'Orbital-shock' technique to managing calcified lesions in patients with previous CABG and in-stent restenosis, and exploring calcium modification strategies tailored to specific cases, these presentations offer valuable insights into simplifying...

Advanced techniques for managing calcified lesions

Complex CTO challenges

22 Sep 2023 – From AICT-AsiaPCR 2023

Gain valuable insights into overcoming CTO challenges in this session: learn how IVUS can come to the rescue in cases of main branch cut-off, discover successful recanalization techniques for right coronary artery CTOs using very long epicardial channels and explore the best approaches for managing complex...

Complex CTO challenges

Learning - Cardiogenic shock

22 Sep 2023 – From AICT-AsiaPCR 2023

Explore the complexities of cardiogenic shock management in this session: understand its pathophysiology, learn about the role of mechanical support (IABP, Impella, ECMO) in addition to pharmacological treatment, gather tips and tricks from expert speakers and gain insights into real-world cases.

Learning - Cardiogenic shock

Transcatheter edge-to-edge repair for challenging situations

19 Feb 2023 – From PCR Tokyo Valves 2023

Explore various innovative repairs repairs: MitraClip for degenerative regurgitation, TEER bridge therapy, successful combined MitraClip and TriClip procedure, and simultaneous mitral repair with LAA closure.

TAVI and alternative access

19 Feb 2023 – From PCR Tokyo Valves 2023

Learn more about TAVI in this session by reviewing case submissions on topics such as bailout transseptal approach, primary percutaneous transaxillary TAVI, and transapical TAVI with chimney stenting. 

Imaging for structural heart disease intervention

19 Feb 2023 – From PCR Tokyo Valves 2023

Consult this session if you want to learn about imaging in structural heart interventions by exploring series of slides on restoration post transcatheter mitral valve repair, diagnostic performance of CT angiography, and AI in aortic complex measurement for TAVI, and more! 

Other cardiac interventions

19 Feb 2023 – From PCR Tokyo Valves 2023

Explore innovative approaches to cardiac interventions featured at PCR Tokyo Valves 2023: from performing TricValve implantation in Asian patients to addressing unique cases like transcatheter valve replacement with a novel tricuspid bioprosthesis. Discover how these experts navigated challenging scenarios!

TAVI in patients with heavily calcified aortic root

19 Feb 2023 – From PCR Tokyo Valves 2023

What role does TAVI play in patients' severely calcified roots? Study the use of balloon-expandable devices, assessing the impact of calcification on aortic root rupture, strategies for safe and effective procedures, and when to consider surgical AVR.

Mitral valve implantation and other technology

19 Feb 2023 – From PCR Tokyo Valves 2023

This session offers insight into advanced mitral valve technologies. It covers details of transapical off-pump repair with synthetic chordae, India's success in transcatheter double valve-in-valve,  TMVI in failing valves, and more.

Coronary access after TAVI

19 Feb 2023 – From PCR Tokyo Valves 2023

Unlock insights into post-TAVI coronary access. Understand transcatheter aortic valve structure, neo-commissure anatomy, and practical techniques. This session covers topics such as optimising commissure alignment, elective CAG/PCI, ACS, and severe aortic stenosis.

AsiaIntervention is the official journal of the Asian-Pacific Society of Interventional Cardiology (APSIC) and the Interventional Cardiology Foundation of India (ICFI)

17 Sep 2018

Keen to see your work in the official journal of APSIC? Submit your manuscript now for a chance to see it featured among the great clinical research articles, expert reviews, case reports and images in cardiology!

AsiaIntervention: SUBMIT YOUR WORK

High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry

25 Feb 2021

The study aimed to evaluate the validity of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria for East Asian patients undergoing contemporary percutaneous coronary intervention (PCI) from the PENDULUM registry.

Authors :

Masato Nakamura, Kazushige Kadota, Koichi Nakao, Yoshihisa Nakagawa, Junya Shite, Hiroyoshi Yokoi, Ken Kozuma, Kengo Tanabe, Raisuke Iijima, Atsushi Harada, Takeshi Kuroda, Yoshitaka Murakami
EuroIntervention: the PENDULUM registry

A short history of the Euro4C Group

16 Jan 2019

Who better to recount its history than the inaugural President of the Euro4C Group? Additionally, insights are provided by the Chairman of PCR, the former EAPCI President, and a pivotal member of the editorial team.

Euro4C Group

Another milestone achieved – Bentley sold its 300,000th BeGraft

07 Jun 2023

Biosensors International Announces Japanese PMDA Approval for BioFreedom™ Ultra and US FDA Approval for BioFreedom™

03 May 2022

iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation

04 Nov 2021

Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...

Nicola Ryan

Author

Nicola Ryan
iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Recruitment complete in FEVAR study for on-label use with Bentley BeGraft as bridging stent

21 Jul 2022

Coronary sinus reducer for microvascular angina

28 Feb 2020

A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...

Coronary sinus reducer for microvascular angina

FDA approves US oriented clinical study of Bentley’s BeGraft and Cook’s Zenith® Fenestrated+ Endovascular Graft for treatment of aortic aneurysms CAUTION: Investigational device. Limited by United States law to investigational use.

28 Jun 2023

BIOMAG-I clinical trial reaches primary endpoint at six month for unique next generation resorbable magnesium scaffold

23 Sep 2022

Didn’t find what you were looking for?